Lenvima 10 MG daily dose 30S
Ended Awarded
- Contract number
- SPE2DB25FTA07
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,354
Award facts
- Contract value 100% obligated
- $11,353.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on September 23, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). This delivery order, issued without a set-aside designation, is expected to reach completion by October 15, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure pharmaceutical products supporting military healthcare facilities worldwide.
As a premier supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards with the Defense Logistics Agency covering an extensive range of branded and generic prescription medications, biologics, and medical consumables. The company's demonstrated capability in distributing specialty pharmaceutical products—including oncology treatments, immunology medications, and other critical care pharmaceuticals—to Department of Defense healthcare sites positions it as a key vendor for meeting the pharmaceutical supply requirements of military medical facilities across the globe.
Quick answers
Who was awarded contract SPE2DB25FTA07?
SPE2DB25FTA07 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FTA07 worth?
The government has obligated $11,354 on SPE2DB25FTA07.
Is contract SPE2DB25FTA07 an order under another contract?
Yes. SPE2DB25FTA07 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FTA07 competed?
The extent of competition for SPE2DB25FTA07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award